Suppr超能文献

使用三种提议定义时代谢综合征中血管疾病的患病率。

Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

作者信息

Athyros Vasilios G, Ganotakis Emmanuel S, Elisaf Moses S, Liberopoulos Evangelos N, Goudevenos Ioannis A, Karagiannis Asterios

机构信息

Atherosclerosis and Metabolic Syndrome Units, 2nd Prop. Department of Internal Medicine, Aristotelian University, Hippocration Hospital, Thessaloniki, Greece.

出版信息

Int J Cardiol. 2007 Apr 25;117(2):204-10. doi: 10.1016/j.ijcard.2006.04.078. Epub 2006 Jul 18.

Abstract

BACKGROUND

There are a number of definitions available for the diagnosis of the metabolic syndrome (MetS). The MetS-associated increase in cardiovascular disease (CVD) risk may depend on the definition used.

AIM

To investigate which of the 3 recently proposed definitions of MetS [the National Cholesterol Education Program-Adult Treatment Panel-III (NCEP-ATP-III), the International Diabetes Federation (IDF) and the American Heart Association/National Heart Lung and Blood Institute (AHA/NHLBI)] is related to excessive CVD risk and thus may be more appropriate to implement in clinical practice.

METHODS

A cross-sectional analysis of a representative sample of Greek adults (n=9669).

RESULTS

The age-adjusted CVD prevalence was 11.4% in the whole study population, 23.3% in the NCEP-ATP-III (+) subjects, 22.6% in AHA/NHLBI (+) subjects and 18.3% in IDF (+) subjects [p<0.001 for the comparison between the whole study population and all MetS groups and p<0.0001 for the comparison between IDF (+) and either NCEP-ATP-III (+) or AHA/NHLBI (+) MetS]. However, the CVD prevalence was only 11.2% in the IDF (+) but NCEP-ATP-III (-)/AHA/NHLBI (-) MetS subjects [p<0.0001 vs. either NCEP-ATP-III (+) or AHA/NHLBI (+)], which was not different compared with the whole study population. Furthermore, subjects with NCEP ATP III (+) or AHA/NHLBI (+) MetS but not diabetes (DM) had a persistently higher prevalence of CVD compared with the whole study population. However, there was no significant difference regarding CVD prevalence between the whole study population and IDF (+)/DM (-) MetS subjects.

CONCLUSIONS

CVD prevalence was increased in the presence of MetS irrespective of the definition used. However, this increase was more pronounced when the NCEP-ATP-III and AHA/NHLBI criteria were implemented compared with the IDF definition. Furthermore, the IDF definition included a large proportion of subjects who did not have increased CVD prevalence compared with the whole study population. These findings may have implications regarding which definition should we use to diagnose the MetS.

摘要

背景

代谢综合征(MetS)的诊断有多种定义。MetS相关的心血管疾病(CVD)风险增加可能取决于所使用的定义。

目的

研究最近提出的3种MetS定义[美国国家胆固醇教育计划成人治疗小组第三次报告(NCEP-ATP-III)、国际糖尿病联盟(IDF)以及美国心脏协会/美国国立心肺血液研究所(AHA/NHLBI)]中哪一种与过高的CVD风险相关,因此可能更适合在临床实践中应用。

方法

对希腊成年人的代表性样本(n = 9669)进行横断面分析。

结果

在整个研究人群中,年龄调整后的CVD患病率为11.4%,NCEP-ATP-III(+)受试者中为23.3%,AHA/NHLBI(+)受试者中为22.6%,IDF(+)受试者中为18.3%[整个研究人群与所有MetS组之间比较,p < 0.001;IDF(+)与NCEP-ATP-III(+)或AHA/NHLBI(+)MetS之间比较,p < 0.0001]。然而,在IDF(+)但NCEP-ATP-III(-)/AHA/NHLBI(-)的MetS受试者中,CVD患病率仅为11.2%[与NCEP-ATP-III(+)或AHA/NHLBI(+)相比,p < 0.0001],与整个研究人群无差异。此外,患有NCEP ATP III(+)或AHA/NHLBI(+)MetS但无糖尿病(DM)的受试者的CVD患病率持续高于整个研究人群。然而,整个研究人群与IDF(+)/DM(-)的MetS受试者之间的CVD患病率无显著差异。

结论

无论使用何种定义,MetS患者的CVD患病率均会升高。然而,与IDF定义相比,采用NCEP-ATP-III和AHA/NHLBI标准时这种升高更为明显。此外,与整个研究人群相比,IDF定义纳入了很大一部分CVD患病率未升高的受试者。这些发现可能对我们应使用哪种定义来诊断MetS具有启示意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验